Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationMatthias Gückenberger, Piet Ost, Christine Verfaillie et al.|The Lancet Oncology|2020Cited by 1.1k
Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic CancerEric J. Lehrer, Nicholas G. Zaorsky, Raj Singh et al.|JAMA Oncology|2020Cited by 189
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusThomas Zilli, Claus Belka, Vérane Achard et al.|Radiotherapy and Oncology|2022Cited by 98
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotypingEvan W. Warner, Alexander W. Wyatt, Kim Van der Eecken et al.|Nature Cancer|2024Cited by 44
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic ReviewKim Van der Eecken, Piet Ost, Jan Vanwelkenhuyzen et al.|European Urology Oncology|2021Cited by 39